Effect of chemotherapy induced hair-loss on distress levels among cancer patients visiting public and private hospitals of Punjab
Effect of chemotherapy induced hair-loss on distress levels among cancer patients
DOI:
https://doi.org/10.54393/pbmj.v5i6.536Keywords:
Chemotherapy induced hair- loss, Distress levels, Public and Private Hospitals, Punjab.Abstract
Chemotherapy is an essential part of a multimodal strategy in the treatment of many cancers. Chemotherapy-induced hair loss is believed to affect 65 percent of people. According to the study, chemotherapy-induced hair loss has been associated to anxiety, depression, a poor body image, low self-esteem, and a decreased sense of health. Objectives: To find out chemotherapy-induced alopecia distress levels among cancer patients' in Punjab's public and private hospitals. To find out the relationship between demographic variables and chemotherapy induced alopecia distress. Methods: A cross sectional study was conducted in public and private hospitals of Punjab, over the duration of 6 months, from October 2021 to March 2022. A sample of 323 respondents with the age range 19-54 was obtained. Data collection tool was adapted version of chemotherapy-induced alopecia distress scale (CASD). Frequencies and percentages of categorical variables were reported and Chi-square test was used to find out associations. Results: High distress level was 61% (n=196) while low distress level was 39% (n=127). Majority of the sample population consisted of participants belonging to age group 18-34 (n=146, 45.2%). Most of them were male 53% (n=173). Respondents diagnosed at stage2 had low distress level (54%) as compare to respondents who were diagnosed at stage3 and stage 4. Significant association (p-value ≤0.05) was found between Gender, family income, employment status, disease stage at diagnosis, number of chemotherapy cycles received and current active treatment. Conclusion: Chemotherapy-induced alopecia distress was associated with all of five domains i.e. physical, emotional, daily activities, relationships and treatment. To reduce the suffering caused by alopecia in cancer patients, appropriate therapies must be developed.
References
American Cancer Society. Cancer facts and figures. Explore Research, Cancer Facts and Statistics.2015 May 15.
Sankaranarayanan R, Ramadas K, Qiao Yl. Managing the changing burden of cancer in Asia. BMC Medicine. 2014;12(3): 10-186.doi.org/10.1186/1741-7015-12-3
Noronha V, Tsomo U, Jamshed A, Hai MA, Wattegama S, Baral RP, et al. A fresh look at oncology facts on south central Asia and SAARC countries. South Asian journal of cancer. 2012 Jul;1(01):01-4. doi.org/10.4103/2278-330X.96489
Del Mastro L, Costantini M, Morasso G, Bonci F, Bergaglio M, Banducci S, et al. Impact of two different dose-intensity chemotherapy regimens on psychological distress in early breast cancer patients. European Journal of Cancer. 2002 Feb;38(3):359-66. doi: 10.1016/s0959-8049(01)00380-x.
Miteva M, Misciali C, Fanti PA, Vincenzi C, Romanelli P, Tosti A. Permanent alopecia after systemic chemotherapy: a clinicopathological study of 10 cases. American Journal of Dermatopathology 2011 Jun;33(4):345-50. doi: 10.1097/DAD.0b013e3181fcfc25.
Kanat O, Ertas H, Caner B. Platinum-induced neurotoxicity: A review of possible mechanisms. World journal of clinical oncology 2017 Aug 10;8(4):329-335. doi: 10.5306/wjco. v8. i4.329.
Rice BA, Ver Hoeve ES, DeLuca AN, Esserman LJ, Rugo HS, Melisko ME. Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy. Breast Cancer Research and Treatment. 2018 Jan 1;167(1):117–122. doi: 10.1007/s10549-017-4506-z.
Breed WPM, Van Den Hurk CJG, Peerbooms M. Presentation, impact and prevention of chemotherapy-induced hair loss: Scalp cooling potentials and limitations. Expert Review of Dermatology. 2011 Feb;6(1):109–25.doi.org/10.1586/edm.10.76
Haslam IS, Smart E. Chemotherapy-induced hair loss: the use of biomarkers for predicting alopecic severity and treatment efficacy. Biomarker Insights. 2019 Apr; 14:1177271919842180.
Rubio-Gonzalez B, Juhász M, Fortman J, Mesinkovska NA. Pathogenesis and treatment options for chemotherapy-induced alopecia: a systematic review. International Journal of Dermatology. 2018 Dec;57(12):1417-1424. doi: 10.1111/ijd.13906.
Paus R, Haslam IS, Sharov AA, Botchkarev VA. Pathobiology of chemotherapy-induced hair loss. The Lancet Oncology. 2013 Feb;14(2): e50-9. doi: 10.1016/S1470-2045(12)70553-3.
Marks DH, Okhovat JP, Hagigeorges D, Manatis-Lornell AJ, Isakoff SJ, Lacouture ME, et al. The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review. Breast Cancer Research Treatment. 2019 Jun 15;175(2):267–76.
Ozusağlam E, Can G. Alterations in sperm long RNA contribute to the epigenetic inheritance of the effects of postnatal trauma. Molecular Psychiatry. 2021;29(3):361–70.
Trüeb RM. Chemotherapy-Induced Alopecia. Seminars in Cutaneous Medicine and Surgery 2009 Mar;28(1):11–4. doi: 10.1016/j.sder.2008.12.001
Grevelman EG, Breed WPM. Prevention of chemotherapy-induced hair loss by scalp cooling. Annals of Oncology. 2005 Mar;16(3):352–8.doi.org/10.1093/annonc/mdi088
Rossi A, Anzalone A, Fortuna MC, Caro G, Garelli V, Pranteda G, et al. Multi-therapies in androgenetic alopecia: review and clinical experiences. Dermatologic therapy 2016 Nov 1;29(6):424–32.doi.org/10.1111/dth.12390
Rugo HS, Klein P, Melin SA, Hurvitz SA, Melisko ME, Moore A, et al. Association between use of a scalp cooling device and alopecia after chemotherapy for breast cancer. Journal of the American Medical Association 2017 Feb 14;317(6):606–14. doi.org/10.1001/jama.2016.21038
Macduff C, Mackenzie T, Hutcheon A, Melville L, Archibald H. The effectiveness of scalp cooling in preventing alopecia for patients receiving epirubicin and docetaxel. European Journal of Cancer Care. 2003 Jun 1;12(2):154–61.doi.org/10.1046/j.1365-2354.2003.00382.x
Lemieux J, Maunsell E, Provencher L. Chemotherapy-induced alopecia and effects on quality of life among women with breast cancer: A literature review. Psychooncology. 2008 Apr;17(4):317–28.doi.org/10.1002/pon.1245
Chon SY, Champion RW, Geddes ER, Rashid RM. Chemotherapy-induced alopecia. Journal of the American Academy of Dermatology 2012 Jul 1;67(1):e37–47.doi.org/10.1016/j.jaad.2011.02.026
Prochilo T, Huscher A, Andreis F, Mirandola M, Zaina E, Pomentale B, et al. Hair Loss Prevention by a Scalp Cooling Device in Early Breast Cancer Patients: The Poliambulanza Preliminary Experience. Reviews on Recent Clinical Trials 2018 Nov 20;14(1):66–71. doi.org/10.2174/1574887113666181120111104
Shin H, Jo SJ, Kim DH, Kwon O, Myung SK. Efficacy of interventions for prevention of chemotherapy-induced alopecia: A systematic review and meta-analysis. International Journal of Cancer. 2015 Mar 1;136(5):E442–54. doi.org/10.1002/ijc.29115
Choi EK, Kim I-R, Chang O, Kang D, Nam S-J, Lee JE, et al. Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients 2014.doi.org/10.1002/pon.3531
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Pakistan BioMedical Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments editor@pakistanbmj.com
